TY - JOUR
T1 - Blood purification therapies in methotrexate-induced acute kidney injury
T2 - Four case reports
AU - Fujikura, Emi
AU - Akiu, Maho
AU - Miyauchi, Kenichiro
AU - Yoshida, Mai
AU - Aoki, Satoshi
AU - Yamamoto, Tae
AU - Narumi, Kaori
AU - Yanagisawa, Noriko
AU - Nakamichi, Takashi
AU - Miyazaki, Mariko
AU - Sato, Hiroshi
AU - Ito, Sadayoshi
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/11/23
Y1 - 2017/11/23
N2 - Background: Methotrexate (MTX), a folic acid antimetabolite, is administered at a high dose for the treatment of diseases such as leukemia and malignant lymphoma. Often, an effort is made to reduce the adverse effects of MTX by monitoring MTX concentration in the blood and administering a high dose of leucovorin. However, side effects of MTX are still reported. MTX is metabolized in the liver and eliminated via the kidneys; hence, blood purification therapy is useful for the reduction of MTX blood concentration in case of renal impairment. Case presentation: We performed various types of blood purification therapies in four cases of MTX poisoning that accompanied renal impairment. Conclusions: Based on our results, we concluded that hemodialysis or hemoperfusion with an activated carbon absorption column was useful for the elimination of MTX from the blood. It is important to choose an appropriate blood purification method understanding the characteristics of each blood purification method.
AB - Background: Methotrexate (MTX), a folic acid antimetabolite, is administered at a high dose for the treatment of diseases such as leukemia and malignant lymphoma. Often, an effort is made to reduce the adverse effects of MTX by monitoring MTX concentration in the blood and administering a high dose of leucovorin. However, side effects of MTX are still reported. MTX is metabolized in the liver and eliminated via the kidneys; hence, blood purification therapy is useful for the reduction of MTX blood concentration in case of renal impairment. Case presentation: We performed various types of blood purification therapies in four cases of MTX poisoning that accompanied renal impairment. Conclusions: Based on our results, we concluded that hemodialysis or hemoperfusion with an activated carbon absorption column was useful for the elimination of MTX from the blood. It is important to choose an appropriate blood purification method understanding the characteristics of each blood purification method.
KW - Acute kidney injury
KW - Blood purification therapy
KW - High-dose methotrexate
KW - Reduction rates
UR - http://www.scopus.com/inward/record.url?scp=85084367796&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084367796&partnerID=8YFLogxK
U2 - 10.1186/s41100-017-0129-4
DO - 10.1186/s41100-017-0129-4
M3 - Article
AN - SCOPUS:85084367796
VL - 3
JO - Renal Replacement Therapy
JF - Renal Replacement Therapy
SN - 2059-1381
IS - 1
M1 - 48
ER -